BPC-157: Complete Research Guide [2026]
BPC-157 is one of the most widely studied peptides in regenerative research. Short for Body Protection Compound-157, this 15-amino acid peptide fragment has generated significant interest for its effects on tissue healing, gut health, and injury recovery in animal models. This guide breaks down what the research actually shows – no hype, just science.
Table of Contents
What Is BPC-157?
BPC-157 (also known as PL 14736 or Bepecin) is a synthetic peptide derived from a protein found in human gastric juice. The naturally occurring parent protein, called Body Protection Compound, was first isolated from human stomach acid in the early 1990s. Researchers then identified the 15-amino acid sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) that appeared responsible for the compound’s biological activity.
Unlike many peptides used in research, BPC-157 is stable in gastric juice. Most peptides break down quickly in the acidic environment of the stomach, but BPC-157 remains active – a property that makes it unusual and interesting from a research standpoint. It is worth noting that a significant portion of the published BPC-157 research comes from the Sikiric group at the University of Zagreb, and independent replication by other laboratories remains limited.
It’s worth noting that BPC-157 does not exist as a standalone molecule in the human body. It is a fragment of a larger protein, and the synthetic version used in research is produced through solid-phase peptide synthesis.
Mechanism of Action
BPC-157’s mechanism of action is complex and not fully understood, but researchers have identified several pathways through which it appears to work:
Angiogenesis Promotion
BPC-157 promotes the formation of new blood vessels (angiogenesis) by upregulating vascular endothelial growth factor (VEGF) expression. This increased blood supply to damaged tissues is thought to be a primary driver of its healing effects. A 2014 study in the Journal of Physiology and Pharmacology demonstrated this effect in a rat tendon healing model (PMID: 25371321).
Nitric Oxide System
The peptide interacts with the nitric oxide (NO) system, which plays a role in blood vessel dilation, inflammation regulation, and tissue repair. Research suggests BPC-157 can modulate NO pathways to promote healing while reducing excessive inflammation (PMID: 27847890).
Growth Factor Modulation
BPC-157 appears to increase expression of growth hormone receptors and interact with multiple growth factor systems, including EGF (epidermal growth factor) and FGF (fibroblast growth factor). These factors are involved in cell growth, differentiation, and tissue repair.
FAK-Paxillin Pathway
Recent research has shown BPC-157 activates the FAK-paxillin signaling pathway, which is involved in cell migration and wound healing. This helps explain its broad tissue-repair effects across different injury types.
Looking for Research-Grade BPC-157?
Core Peptides offers third-party tested BPC-157 with full certificates of analysis. Trusted by researchers nationwide.
Key Research Findings
BPC-157 has been the subject of hundreds of studies, primarily in animal models. Here are the most significant findings:
Tendon and Ligament Healing
Multiple studies have shown BPC-157 accelerates tendon healing in rats. A study by Staresinic et al. (2006) demonstrated faster healing of transected Achilles tendons with BPC-157 treatment compared to controls (PMID: 16581060). The treated tendons showed better biomechanical properties and more organized collagen fibers.
Gastrointestinal Protection
As a compound derived from gastric juice, BPC-157 has been extensively studied for gut-protective effects. Research shows it can counteract lesions induced by NSAIDs, alcohol, and other damaging agents in animal models. Sikiric et al. published a comprehensive review covering these gastrointestinal effects (PMID: 24186079).
Muscle Healing
BPC-157 has demonstrated the ability to accelerate muscle healing after crush injuries in rats. A 2010 study showed faster functional recovery and improved muscle fiber regeneration compared to saline controls (PMID: 20225319).
Bone Healing
Animal studies suggest BPC-157 can promote bone healing. Research in rabbit segmental bone defect models showed improved bone formation markers and faster healing with BPC-157 administration (PMID: 19340479).
Neuroprotective Effects
Several studies have explored BPC-157’s effects on the nervous system. Research shows potential neuroprotective properties, including protection against dopaminergic neurotoxicity and promotion of peripheral nerve regeneration (PMID: 20388509).
Important Limitations
Nearly all BPC-157 research has been conducted in animal models – primarily rats and mice. There are very few published human clinical trials. This is a significant limitation when extrapolating results. The peptide’s effects in humans may differ substantially from what has been observed in rodent studies.

Common Research Applications
Based on the published literature, BPC-157 is commonly used in research settings to study:
- Soft tissue healing mechanisms (tendons, ligaments, muscles)
- Gastrointestinal mucosal protection and repair
- Angiogenesis and blood vessel formation
- Inflammatory bowel disease models
- Nerve regeneration and neuroprotection
- Drug-induced organ damage (NSAID gastropathy, alcohol toxicity)
- Wound healing pathways
Researchers interested in tissue repair peptides often study BPC-157 alongside TB-500 (Thymosin Beta-4), as the two peptides appear to work through complementary pathways.
Compare Top BPC-157 Suppliers
We tested and reviewed the leading peptide vendors so you don’t have to. See which ones passed our purity verification.
Reconstitution and Dosing Information
Note: The following information is provided strictly for research purposes. BPC-157 is not approved for human use by the FDA or any regulatory agency.
Reconstitution
BPC-157 typically comes as a lyophilized (freeze-dried) powder. To prepare it for research use:
- Use bacteriostatic water (BAC water) as the reconstitution solvent
- Allow the BAC water to run gently down the inside wall of the vial – do not spray directly onto the powder
- Gently swirl the vial until the powder dissolves completely – do not shake vigorously
- The solution should be clear and colorless once reconstituted
A common reconstitution ratio is 2 mL of BAC water per 5 mg vial, yielding a concentration of 2.5 mg/mL (2,500 mcg/mL).
Research Dosing
In animal studies, BPC-157 has been administered at doses ranging from 1-10 mcg/kg body weight, with most studies using approximately 10 mcg/kg. The peptide has been studied via subcutaneous injection (most common), intramuscular injection, intraperitoneal injection, and oral administration.
For more information on reconstitution techniques, see our complete peptide reconstitution guide.

Storage Requirements
- Lyophilized (powder form): Store at -20°C for long-term storage. Stable at room temperature for short periods during shipping, but should be refrigerated or frozen upon receipt.
- Reconstituted solution: Store at 2-8°C (standard refrigerator temperature). Use within 2-4 weeks for best results.
- Avoid: Repeated freeze-thaw cycles, direct sunlight, and temperatures above 25°C for extended periods.
- Bacteriostatic water: The benzyl alcohol preservative in BAC water helps prevent bacterial growth in reconstituted solutions, but proper aseptic technique during reconstitution is still important.
New to Peptide Research?
Start with our complete peptide guide covering everything from reconstitution to storage protocols.
Potential Side Effects from Research Literature
BPC-157 has shown a favorable safety profile in animal studies. Key observations include:
- No reported organ toxicity: Toxicology studies in rats have not identified significant organ damage even at high doses (PMID: 21030672).
- No reported LD50: Researchers have been unable to establish a lethal dose in animal models, suggesting a wide safety margin.
- Potential concerns: Because BPC-157 promotes angiogenesis, there are theoretical concerns about its use in the context of existing tumors or cancerous conditions, as increased blood vessel formation could support tumor growth. This has not been studied extensively.
- Injection site reactions: As with any injectable compound, localized redness, swelling, or discomfort at the injection site is possible.
The lack of completed human clinical trials means the full side effect profile in humans remains unknown. Any research use should be conducted with appropriate safety protocols.

Where to Source Quality BPC-157
Quality matters enormously with research peptides. Low-quality BPC-157 may contain impurities, incorrect sequences, or insufficient peptide content. When sourcing BPC-157 for research, look for:
- Third-party Certificates of Analysis (COAs) with HPLC purity results above 98%
- Mass spectrometry verification confirming correct molecular weight (1,419.53 Da)
- Transparent sourcing and manufacturing information
- Proper packaging and cold-chain shipping options
We’ve reviewed and compared the top peptide suppliers in our Best Peptide Companies [2026] guide, rating them on purity, price, testing, and customer service.
Frequently Asked Questions
What is BPC-157 derived from?
BPC-157 is a synthetic 15-amino acid peptide derived from a larger protein called Body Protection Compound, which is naturally found in human gastric juice. The synthetic version is produced through solid-phase peptide synthesis and does not exist as a standalone molecule in the human body.
Is BPC-157 FDA approved?
No. BPC-157 is not approved by the FDA for any medical use. It is classified as a research chemical. In November 2023, the FDA added BPC-157 to its list of compounds that cannot be used in compounding pharmacies. It is available for purchase as a research peptide only.
How is BPC-157 typically administered in research studies?
In animal research studies, BPC-157 has been administered via subcutaneous injection (most common), intramuscular injection, intraperitoneal injection, and oral administration. Doses in animal studies typically range from 1-10 mcg/kg body weight.
What is the difference between BPC-157 and BPC-157 Acetate?
BPC-157 Acetate is simply BPC-157 with an acetate salt form. The acetate salt is added during manufacturing to improve stability and solubility. Both forms contain the same active 15-amino acid sequence and are functionally equivalent for research purposes.
Can BPC-157 be taken orally?
In animal research, BPC-157 has shown oral bioactivity, which is unusual for a peptide. Most peptides are broken down by digestive enzymes, but BPC-157 demonstrates stability in gastric juice. Several animal studies have used oral administration routes with positive results, particularly for gastrointestinal research applications.
References
- Seiwerth S, et al. “BPC 157’s effect on healing.” J Physiol Pharmacol. 2014. PMID: 25371321
- Sikiric P, et al. “Brain-gut axis and pentadecapeptide BPC 157.” Curr Neuropharmacol. 2016. PMID: 27847890
- Staresinic M, et al. “Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon.” J Orthop Res. 2006. PMID: 16581060
- Sikiric P, et al. “Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease.” Inflamm Bowel Dis. 2013. PMID: 24186079
- Novinscak T, et al. “Gastric pentadecapeptide BPC 157 and muscle healing.” J Physiol Pharmacol. 2010. PMID: 20225319
Disclaimer: This article is for informational and research purposes only. BPC-157 is not approved for human use. Nothing in this guide should be taken as medical advice. Always consult a qualified healthcare professional before making any health-related decisions.